<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="347548">
  <stage>Registered</stage>
  <submitdate>3/10/2011</submitdate>
  <approvaldate>6/10/2011</approvaldate>
  <actrnumber>ACTRN12611001049965</actrnumber>
  <trial_identification>
    <studytitle>The effectiveness of Bodyflow therapy post Total Knee Replacement surgery: post-operation hospitalization duration and patient recovery.</studytitle>
    <scientifictitle>The effectiveness of Bodyflow therapy post Total Knee Replacement surgery: post-operation hospitalization duration and patient recovery.</scientifictitle>
    <utrn>U1111-1124-9736</utrn>
    <trialacronym />
    <secondaryid>Nil.</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Total Knee Replacement</healthcondition>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Low voltage electrical stimulation of muscles to reduce post-surgery oedema. Therapy is delivered by placing 1 pair of skin electrodes just above the knee, and another pair just below the knee that was operated on. Low voltage (&lt;5V) pulses will slightly stimulate the muscles in thigh and calf which will help reduction of oedema. Treatment is started 2 days post operation with in-hospital treatment, until the day of hospital discharge. From that day on the patient will administer the treatment at home (using a handheld device) until 2 weeks after operation. Treatments are administered in 3-4 sessions of 20 minutes daily. This treatment is in addition to the standard care.</interventions>
    <comparator>Placebo group and Standard Treatment group: the placebo group will have all electrodes etc applied as for 'normal' stimulation, but the intensity of stimulus will be too low (or absent) to trigger any effect on the muscles. The patient is blinded to whether or not stimulation occurs, and will receive the standard care. The Standard group will not get any Bodyflow treatment (or simulation of it), only the standard care of compression socks.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Reduction of post-surgery hospital stay duration</outcome>
      <timepoint>Hospital discharge + 14-days post-op.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Reduction of oedema. Assessed by circumferential measurements at 4 specified positions of the treated leg.</outcome>
      <timepoint>Hospital discharge + 14-days post-op.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Reduction of pain, as assessed by the patient's score on a 10-point visual scale (VAS).</outcome>
      <timepoint>Hospital discharge + 14-days post-op.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Candidates for Total Knee Replacement surgery</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients with a past history of Deep Vein Thrombosis or Thromboembolic event,
Patients with an implanted pacemaker or Internal Cardioverter Defibrillator,  
Pregnant women, 
Patients suffering from Diabetes type 1,
Patients whom have a bleeding disorder such as Haemophilia or associated Coagulopathy</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>sealed envelopes, opened after end of surgery.</concealment>
    <sequence>Permuted block randomisation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>7/10/2011</anticipatedstartdate>
    <actualstartdate>31/10/2011</actualstartdate>
    <anticipatedenddate />
    <actualenddate>5/10/2012</actualenddate>
    <samplesize>72</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Terminated</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Bodyflow International PTY LTD</primarysponsorname>
    <primarysponsoraddress>2 Islington Street
Collingwood 
Victoria 3066</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>Sportsmed SA</othercollaboratorname>
      <othercollaboratoraddress>32 Payneham Rd
Stepney SA 5069</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study evaluates the effects of adding Bodyflow therapy to the standard of care treatment after patients underwent a surgical procedure for total knee replacement (TKR). The Bodyflow treatment will consist of an in-hospital component, as well as a self-administered component after the patient has been discharged. The effect of the treatment on the duration of the post-operative hospital stay will be the primary objective, while its effects on peripheral tissue oedema and patients pain scores are evaluated as secondary objectives.</summary>
    <trialwebsite>nil</trialwebsite>
    <publication>nil</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>BellBerry</ethicname>
      <ethicaddress>229 Greenhill Road
Dulwich
South Australia 5065</ethicaddress>
      <ethicapprovaldate>3/05/2011</ethicapprovaldate>
      <hrec>2011-01-004</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Mr</title>
      <name>Genn Dods,  Physiotherapist</name>
      <address>SPORTSMED SA
ORTHOPAEDIC DEPT
32 PAYNEHAM RD
STEPNEY  SA   5069</address>
      <phone>+61 8 8130 1222</phone>
      <fax>+61 8 8130 6635</fax>
      <email>glenn.dods@sportsmed.com.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Genn Dods,  Physiotherapist</name>
      <address>SPORTSMED SA
ORTHOPAEDIC DEPT
32 PAYNEHAM RD
STEPNEY  SA   5069</address>
      <phone>+61 8 8130 1222</phone>
      <fax>+61 8 8130 6635</fax>
      <email>glenn.dods@sportsmed.com.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Henri Heijnen</name>
      <address>TechMed Research Pty Ltd
PO Box 2355
Lower Templestowe VIC 3107
Australia</address>
      <phone>+61 435 771 943</phone>
      <fax>nil</fax>
      <email>hheijnen@iprimus.com.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Tony Spriggins</name>
      <address>Sportsmed SA, orthopaedic dept.
32 Payneham rd
Stepney SA 5069</address>
      <phone>+61 8 8130 1222 </phone>
      <fax />
      <email>tony_spriggins@msn.com.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>